New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 20, 2014
08:24 EDTSTEMStemCells price target raised to $5.00 from $2.50 at Maxim
After reviewing StemCells' proof of concept data in an early dry-AMD trial, Maxim doubled its price target on the shares and said its new $5.00 target could still be conservative. The firm thinks dry-AMD has the potential to be a blockbuster opportunity that could be transformational for StemCells and keeps a Buy rating on the stock.
News For STEM From The Last 14 Days
Check below for free stories on STEM the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 23, 2014
09:06 EDTSTEMCapital Ventures International reports 6.5% passive stake in StemCells
July 15, 2014
10:25 EDTSTEMStemCells files to sell $20M in common stock and warrants (pre-open)
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use